ID   ONS-21
AC   CVCL_5G58
SY   Osaka Neurological Surgery-21
DR   Wikidata; Q54936422
RX   DOI=10.1016/B978-0-12-333530-2.50005-8;
RX   PubMed=1992917;
RX   PubMed=2395860;
CC   Population: Japanese.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C4326; Anaplastic oligodendroglioma
DI   ORDO; Orphanet_251630; Anaplastic oligodendroglioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
RX   DOI=10.1016/B978-0-12-333530-2.50005-8;
RA   Nister M., Westermark B.;
RT   "Human glioma cell lines.";
RL   (In book chapter) Atlas of human tumor cell lines; Hay R.J., Park J.-G., Gazdar A.F. (eds.); pp.17-42; Academic Press; New York; USA (1994).
//
RX   PubMed=1992917;
RA   Mabuchi E., Shimizu K., Yamada M., Moriuchi S., Park K., Tamura K.,
RA   Hayakawa T., Mogami H.;
RT   "In vitro chemosensitivity test with several antitumor agents against
RT   eight malignant brain tumor cell-lines.";
RL   Gan To Kagaku Ryoho 18:233-238(1991).
//
RX   PubMed=2395860; DOI=10.1073/pnas.87.17.6584; PMCID=PMC54581;
RA   Okamoto Y., Minamoto S., Shimizu K., Mogami H., Taniguchi T.;
RT   "Interleukin 2 receptor beta chain expressed in an oligodendroglioma
RT   line binds interleukin 2 and delivers growth signal.";
RL   Proc. Natl. Acad. Sci. U.S.A. 87:6584-6588(1990).
//